In memory of our Founder, Paul G. Allen

Learn More

Paul G. Allen, 1953-2018

“Paul’s vision and insight have been an inspiration to me and to many others both here at the Institute that bears his name, and in the myriad of other areas that made up the fantastic universe of his interests. He will be sorely missed. We honor his legacy today, and every day into the long future of the Allen Institute, by carrying out our mission of tackling the hard problems in bioscience and making a significant difference in our respective fields.”

Allan Jones
President and CEO, Allen Institute

News

News

The genes that build our brains — and may drive neuropsychiatric diseases

December 17, 2018

Data from 60 human brains reveal how gene activity changes from before we are born to adulthood, pinpoint cells where psychiatric disorders may arise

Press Release

Announcing the Allen Institute for Immunology, a new research endeavor focused on human immune health and disease

December 12, 2018

Seeded by $125 million donation by the late Paul G. Allen, the Allen Institute for Immunology will study human immune health, cancer, and autoimmune diseases

Video

Meet the Allen Institute for Immunology’s research partners

December 12, 2018

The new Institute will work directly with samples and data from patients with immune-related diseases and healthy volunteers, thanks to a unique partnership with five leading research organizations. 

Video

Allen Cell Methods: Techniques while working with Matrigel

December 10, 2018

To ensure researchers have success working with our human iPS cell lines in their lab, our Angel Nelson highlights helpful tips while working with Matrigel.

News

Two years of glowing cells for science

December 6, 2018

The Allen Cell Collection, debuted in 2016, houses cells labeling 27 different structures — and is now available for research use in both non-profit and for-profit communities

News

This human neuron is on a different wavelength than its mouse counterpart

December 5, 2018

Study uncovers subtle differences in how rodents and humans use the same kind of brain cell, could have implications for drug and disease research